Prof. Pablo Fernandez-Penas discusses the important role of VECTRA® WB360 in the launch of ACEMID
Prof. Pablo Fernandez-Penas of the University of Sydney was recently interviewed on 7News Australia as the University of Queensland and the Australian Cancer Research Foundation announced the official launch of the Australian Centre of Excellence in Melanoma Imaging and Diagnosis (ACEMID). Prof. Fernandez-Penas highlighted the VECTRA WB360 and explained how 15 WB360 systems will be installed as part of this initiative bringing together researchers from the University of Queensland, University of Sydney, and Monash University to study melanoma using the system’s advanced body mapping technology. Prof. Penas is hopeful that up to 15,000 Australians across the states of Queensland, New South Wales, and Victoria will take part in future screenings using the VECTRA WB360, enabling researchers to collect images and develop advanced algorithms to aide melanoma detection.
Recent News in In The Media
- Advancing Skin Screenings: Dr. Charles E. Mount III and Director Howard Edington, MD Discuss VECTRA® WB360 at AHN Cancer Institute with CBS News
- Dr. Robyn Siperstein, M.D., discusses Canfield’s revolutionary AI & AR technology and its role in consultations in MedEsthetics Magazine
- Canfield’s VECTRA® WB360 recently installed at Allegheny Health Network Cancer Institute
- Dr. Sherina Balaratnam discusses with Francesca Ogiermann-White why Canfield’s VISIA® is an essential part of all her consultations
Most Recent News
- Advancing Skin Screenings: Dr. Charles E. Mount III and Director Howard Edington, MD Discuss VECTRA® WB360 at AHN Cancer Institute with CBS News
- National Doctors’ Day, Spotlighting Glynis Ablon, MD, FAAD
- Dr. Robyn Siperstein, M.D., discusses Canfield’s revolutionary AI & AR technology and its role in consultations in MedEsthetics Magazine
- VISIA®’s 5th Consecutive Win as Favorite Diagnostic Tool in Dermascope’s Aestheticians’ Choice Awards!